#IDDF2024

Programme

Room N101B
2024-08-10
09:00-10:30
AASLD-HKASLD Joint Symposium (1): Hepatitis B
09:00
Indeterminate Phase of Chronic Hepatitis B – What Is It and Does It Matter?
09:25
New Pharmacological Treatments for Chronic Hepatitis B
09:50
The Impact of New Guidelines on Managing Hepatitis B
10:15
Q & A
Room N101B
2024-08-10
11:00-12:30
Viral Hepatitis
11:00
Novel HBV and HCV Viral Markers for Diagnosis and On-Treatment Monitoring
11:25
Navigating The Various Realms of Hepatitis B With The Latest Treatment
12:15
Q & A
Room N101B
2024-08-10
15:50-17:20
New Development in Hepatology
15:50
What Can We Learn from Auto-Brewery Syndrome
16:15
Management of Critically Ill Patients with Cirrhosis
17:05
Q & A
Room N101B
2024-08-10
17:20-18:20
Towards Functional Cure of HBV
17:20
The Role of MTCT of HBV in Hepatitis Elimination
18:10
Q & A
Room N101B
2024-08-11
09:00-10:30
AASLD-HKASLD Joint Symposium (2): Advanced Liver Disease
09:00
Management of Patients in The Baveno VII Gray Zone
09:25
Role of Gut Microbiota in Advanced Liver Disease
09:50
Use of Vasoactive Drugs and Albumin in Cirrhosis
10:15
Tea Break
Room N101B
2024-08-11
11:00-12:15
General Hepatology Update
11:00
Lean MAFLD
11:25
HCC Risk Prediction – Is There Room for Improvement?
11:50
Micro-elimination of HCV in Hong Kong
AASLD-HKASLD Joint Symposium (1): Hepatitis B
Room N101B
2024-08-10
09:00
09:00
Indeterminate Phase of Chronic Hepatitis B – What Is It and Does It Matter?
09:25
New Pharmacological Treatments for Chronic Hepatitis B
09:50
The Impact of New Guidelines on Managing Hepatitis B
10:15
Q & A
Viral Hepatitis
Room N101B
2024-08-10
11:00
11:00
Novel HBV and HCV Viral Markers for Diagnosis and On-Treatment Monitoring
11:25
Navigating The Various Realms of Hepatitis B With The Latest Treatment
12:15
Q & A
New Development in Hepatology
Room N101B
2024-08-10
15:50
15:50
What Can We Learn from Auto-Brewery Syndrome
16:15
Management of Critically Ill Patients with Cirrhosis
17:05
Q & A
Towards Functional Cure of HBV
Room N101B
2024-08-10
17:20
17:20
The Role of MTCT of HBV in Hepatitis Elimination
18:10
Q & A
AASLD-HKASLD Joint Symposium (2): Advanced Liver Disease
Room N101B
2024-08-11
09:00
09:00
Management of Patients in The Baveno VII Gray Zone
09:25
Role of Gut Microbiota in Advanced Liver Disease
09:50
Use of Vasoactive Drugs and Albumin in Cirrhosis
10:15
Tea Break
General Hepatology Update
Room N101B
2024-08-11
11:00
11:00
Lean MAFLD
11:25
HCC Risk Prediction – Is There Room for Improvement?
11:50
Micro-elimination of HCV in Hong Kong
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
Follow Us
#IDDF2024
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
Speaker
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
Follow Us
#IDDF2024
SECRETARIAT
MIMS (Hong Kong) Limited

37/F., Citicorp Centre,
18 Whitfield Road,
Causeway Bay, Hong Kong
‍
E: info@iddforum.com
T: (852) 2116 4320
F: (852) 2559 6910
Organizers
PATRON:
Copyright © 2024. All Rights Reserved. Institute of Digestive Disease, The Chinese University of Hong Kong. Privacy | Disclaimer